PharmiWeb.com - Global Pharma News & Resources
10-Jul-2019

Controlled Release Drug Delivery Market Size to Cross USD 91.2 Bn by 2026

The global Controlled Release Drug Delivery Market Size is anticipated to around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period 2018 to 2026. Surge in technological penetration in healthcare sector is expected to drive the growth of the global controlled release drug delivery market. Also, increased patient engagement and awareness of technology are anticipated to boot the market over the forthcoming years.

Soaring demand for pediatric and geriatric controlled release delivery methods and substitute therapies and increasing consciousness about advantages of these systems over conventional forms are providing a fillip to the controlled release drug delivery market.

These technologies deliver numerous advantages over old-style delivery forms. Uniform drug effect, reduced dosage and less gastrointestinal side effects, dosage frequency, enhanced patient compliance, improved drug efficacy amp; safety, and reduced fluctuation of plasma drug levels are some of the advantages delivered by these technologies.

Increase in acceptance of advance and improvised healthcare gadgets are the other reason for the development of the global controlled release drug delivery market. Apart from this various features such as timely delivery of drug is another factor triggering the market development.

Increasing awareness concerning the antagonistic effects of non-adherence is calculable to surge the controlled unharness drug delivery trade growth. Awareness relating to the advantages of connected systems over the standard systems is additionally anticipated to drive the controlled unharness drug delivery market growth across the world over the approaching years.

Download Free Report Sample Pages at https://www.acumenresearchandconsulting.com/request-sample/981

The global controlled release drug delivery market is bifurcated into four major segment named application, release mechanism, technology, and region. On the basis of the application the global controlled release drug delivery market is segmented into metered dose inhalers, injectable, transdermal and ocular patches, infusion pumps, oral controlled-drug delivery systems, and drug eluting stents. On the basis of release mechanism the controlled release drug delivery market is segmented into Polymer based systems, micro reservoir partition controlled drug delivery systems, feedback regulated drug delivery systems, and activation-modulated drug delivery systems, and chemically activated. These activation-modulated drug delivery systems are further bifurcated into osmotic pressure activated, hydrodynamic pressure activated, vapor pressure activated, mechanically activated, and magnetically activated. The chemically activated is also further segmented into ph activated, hydrolysis activated, and enzyme activated. On the basis of technology, the controlled release drug delivery market is segmented into wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery, and others. On the basis of region the global controlled release drug delivery market is segmented into Asia Pacific, North America, Latin America Europe, and Middle East amp; Africa.

Controlled release drug delivery systems permit reduction in quantity of dose and dose frequency, increased patient compliance and acceptance, less fluctuation in plasma drug levels, uniform drug result, and improved effectualness quantitative relation of administered therapeutic. as compared to traditional delivery, these systems accomplish a chronic therapeutic result, increase foregone conclusion in drug unleash dynamics, and produce concerning delivery at a pre-determined rate regionally or consistently. Thus, with many more blessings offered by these systems, their adoption is slated to extend at a motivating rate over the approaching years.

North America captures the largest revenue share at 35.6% and will continue to retain its dominance position over the forthcoming years. Speedy acceptance of advanced devices and technologies and high per capita healthcare expenditure are expected to surge the need for connected drug delivery systems in the region. High price of controlled release drug delivery is expected to be the one of the substantial factor in hampering the market growth in emerging regions such as MEA, APAC and Latin America. Though, with the growing numeral of market entrants the device prices are anticipated to fall over time; this will backing the market growth in emerging such countries such as India and China.

The key players operating in the global controlled release drug delivery market are Capsugel, Orbis Biosciences, Inc., Pfizer, Inc, Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Depomed, Inc., Corium International, Inc., and Aradigm Corporation. These market participants are investing enormous wealth to revolutionise the product line as the rivalry in the market is growing with rapid pace. Likewise, with varying technology the demand for better healthcare infrastructures are growing, so cater the demand of the customers, market participants are continuously inventing new products.

View Detail Report at https://www.acumenresearchandconsulting.com/controlled-release-drug-delivery-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Controlled Release Drug Delivery
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Controlled Release Drug Delivery Market By Release Mechanism
1.2.2.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Release Mechanism (2015-2026)
1.2.2.2. Global Controlled Release Drug Delivery Market Revenue Share By Release Mechanism in 2017
1.2.2.3. Polymer Based Systems
1.2.2.4. Micro Reservoir Partition Controlled Drug Delivery Systems
1.2.2.5. Feedback Regulated Drug Delivery Systems
1.2.2.6. Activation-modulated Drug Delivery Systems
1.2.2.7. Chemically Activated
1.2.2.8. Others
1.2.3. Controlled Release Drug Delivery Market By Technology
1.2.3.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Wurster Technique
1.2.3.3. Coacervation
1.2.3.4. Micro Encapsulation
1.2.3.5. Implants
1.2.3.6. Transdermal
1.2.3.7. Targeted Delivery
1.2.3.8. Others
1.2.4. Controlled Release Drug Delivery Market By Application
1.2.4.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Metered Dose Inhalers
1.2.4.3. Injectable
1.2.4.4. Transdermal and Ocular Patches
1.2.4.5. Infusion Pumps
1.2.4.6. Oral Controlled-drug delivery Systems
1.2.4.7. Drug Eluting Stents
1.2.4.8. Others
1.2.5. Controlled Release Drug Delivery Market by Geography
1.2.5.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Controlled Release Drug Delivery Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Controlled Release Drug Delivery Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Controlled Release Drug Delivery Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Controlled Release Drug Delivery Major Manufacturers in 2017

CHAPTER 4. CONTROLLED RELEASE DRUG DELIVERY MARKET BY RELEASE MECHANISM

4.1. Global Controlled Release Drug Delivery Revenue By Release Mechanism
4.2. Polymer Based Systems
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Micro Reservoir Partition Controlled Drug Delivery Systems
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Feedback Regulated Drug Delivery Systems
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Activation-modulated Drug Delivery Systems
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Chemically Activated
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Other
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY

5.1. Global Controlled Release Drug Delivery Revenue By Technology
5.2. Wurster Technique
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Coacervation
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Micro Encapsulation
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Implants
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Transdermal
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Targeted Delivery
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Others
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. CONTROLLED RELEASE DRUG DELIVERY MARKET BY APPLICATION

6.1. Global Controlled Release Drug Delivery Revenue By Application
6.2. Metered Dose Inhalers
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Injectable
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Transdermal and Ocular Patches
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Infusion Pumps
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Oral Controlled-drug delivery Systems
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Drug Eluting Stents
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.8. Others
6.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

7.1. North America Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Controlled Release Drug Delivery Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

8.1. Europe Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

9.1. Asia-Pacific Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

10.1. Latin America Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

11.1. Middle East Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

12.1. Africa Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Capsugel
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Orbis Biosciences, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Pfizer, Inc
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Merck and Co., Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Johnson and Johnson
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Alkermes plc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Coating Place, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Depomed, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Corium International, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Aradigm Corporation
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING: https://www.acumenresearchandconsulting.com/inquiry-before-buying/981

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/981

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 10-Jul-2019